Preparation for treatment of spinal cord injury
US9040062B2 · kind B2 · utility
520Cited by
6References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 4, 2011 |
| Grant date | May 26, 2015 |
| Priority date | — |
| Expiry date | Aug 4, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is a solid sustained-release formulation comprising an agent for inhibiting semaphorin 3A as an active ingredient, which comprises an agent for inhibiting semaphorin 3A and pharmaceutically acceptable hardly water-soluble solid substance, in which the carrier is silicone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.